Year: 2022
Type: review
Source: Nature Reviews Nephrology
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, chronic kidney disease, heart failure, cardiovascular outcomes, renal outcomes, type 2 diabetes, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, anemia, hyperkalemia, hypoglycemia, acute kidney injury, drug safety, mechanism of action
Open Access status: green
OpenAlex ID: W4211210537
